Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,520 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis B.
Buti M, Heo J, Tanaka Y, Andreone P, Atsukawa M, Cabezas J, Chak E, Coffin CS, Fujiwara K, Gankina N, Gordon SC, Janczewska E, Komori A, Lampertico P, McPherson S, Morozov V, Plesniak R, Poulin S, Ryan P, Sagalova O, Sheng G, Voloshina N, Xie Q, Yim HJ, Dixon S, Paff M, Felton L, Lee M, Greene T, Lim J, Lakshminarayanan D, McGonagle G, Plein H, Youssef AS, Elston R, Kendrick S, Theodore D. Buti M, et al. Among authors: dixon s. J Hepatol. 2024 Aug 29:S0168-8278(24)02488-7. doi: 10.1016/j.jhep.2024.08.010. Online ahead of print. J Hepatol. 2024. PMID: 39214467 Free article.
Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label Extension.
Adams D, Wixner J, Polydefkis M, Berk JL, Conceição IM, Dispenzieri A, Peltier A, Ueda M, Bender S, Capocelli K, Jay PY, Yureneva E, Obici L; patisiran Global OLE study group. Adams D, et al. JAMA Neurol. 2025 Jan 13. doi: 10.1001/jamaneurol.2024.4631. Online ahead of print. JAMA Neurol. 2025. PMID: 39804640
Hydroxychloroquine prevents resistance and potentiates the antitumor effect of SHP2 inhibition in NF1-associated malignant peripheral nerve sheath tumors.
Sait SF, Tang KH, Angus SP, Brown R, Sun D, Xie X, Iltis C, Lien M, D Socci N, Bale TA, Davis C, Dixon SAH, Zhang C, Wade Clapp D, Neel BG, Parada LF. Sait SF, et al. Among authors: dixon sah. Proc Natl Acad Sci U S A. 2025 Jan 7;122(1):e2407745121. doi: 10.1073/pnas.2407745121. Epub 2024 Dec 30. Proc Natl Acad Sci U S A. 2025. PMID: 39793045
Monitoring of cancer ferroptosis with [18F]hGTS13, a system xc- specific radiotracer.
Moses A, Malek R, Kendirli MT, Cheung P, Landry M, Herrera-Barrera M, Khojasteh A, Granucci M, Bukhari SA, Hooper JE, Hayden-Gephart M, Dixon SJ, Recht LD, Beinat C. Moses A, et al. Among authors: dixon sj. Theranostics. 2025 Jan 1;15(3):836-849. doi: 10.7150/thno.101882. eCollection 2025. Theranostics. 2025. PMID: 39776801 Free PMC article.
Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial.
Gross AM, O'Sullivan Coyne G, Dombi E, Tibery C, Herrick WG, Martin S, Angus SP, Shern JF, Rhodes SD, Foster JC, Rubinstein LV, Baldwin A, Davis C, Dixon SAH, Fagan M, Ong MJ, Wolters PL, Tamula MA, Reid O, Sankaran H, Fang F, Govindharajulu JP, Browne AT, Kaplan RN, Heisey K, On TJ, Xuei X, Zhang X, Johnson BC, Parchment RE, Clapp DW, Srivastava AK, Doroshow JH, Chen AP, Widemann BC. Gross AM, et al. Among authors: dixon sah. Nat Med. 2025 Jan 6. doi: 10.1038/s41591-024-03361-4. Online ahead of print. Nat Med. 2025. PMID: 39762421
Top ten menopause research priorities.
Nash Z, Christmas M, Gronlund T, Hickey M; Menopause Priority Setting Partnership Steering Group. Nash Z, et al. Lancet. 2025 Dec 21;404(10471):2535-2536. doi: 10.1016/S0140-6736(24)02602-3. Lancet. 2025. PMID: 39709195 No abstract available.
1,520 results